Accueil   Diary - News   All news Theranexus announces appointment of Jérôme MARTINEZ to its board of directors

Theranexus announces appointment of Jérôme MARTINEZ to its board of directors

Lyon, 14 December 2018 – Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction between neurons and glial cells, today announces the appointment of Jérôme Martinez, Chairman of BMI SYSTEM, as an independent director on its Board of Directors. Martinez is set to replace steping down Ms Celia Hart, representative of the investment fund Amorçage Technologique Investissement SAS – a fund managed by the asset management firm Supernova Invest. Martinez’s appointment will be subject to ratification at the next shareholder’s meeting.

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree